May 31, 2011
Abbott Laboratories and the Wisconsin Alumni Research Foundation slapped a Boehringer Ingelheim GmbH unit with a patent infringement suit on Thursday in Delaware seeking to block the injectable drug specialist from producing its own version of kidney disease treatment Zemplar.